000			03156nam a22003735i 4500
001			80516
003			ES-MaUEC
005			20230207040308.0
007			cr nn 008mamaa
008			140213s2014 gw | s |||| 0|eng d
020			_a9783642395901
024	7		_a10.1007/978-3-642-39590-1 _2doi
050		4	_aRC280.L9 _bR374 2014
245	1	0	_aRare Lymphomas _cedited by Martin Dreyling, Michael E. Williams.
260			_aBerlin, Heidelberg _bSpringer _c2014
300			_a1 recurso en línea (X, 364 páginas) _b80 ilustraciones, 70 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	0		_aHematologic Malignancies
505	0		_aI General:ÂСthology -- Cytogenetics -- Molecular Genetics -- Signal Pathways -- II Disease-specific: T-NHL: Acute T-cell leukemia -- Anaplastic lymphoma -- Nasal/NK-cell lymphoma -- Cutaneous T-cell lymphoma -- B-NHL: Adult Burkitt -- Primary Mediastinal Lymphoma -- CNS Lymphoma -- HIV-Associated lymphoma -- Marginal Zone Lymphoma -- MALT -- MCL -- Waldenstroem -- PLL -- Llymphocyte Predominant Hodgkin -- Cutaneous B-cell lymphoma.
520	3		_aThe past decade has witnessed tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma as well as in understanding of the underlying molecular pathogenesis. Optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors. Even more importantly, molecular targeted approaches have been shown to be effective in the treatment of distinct lymphoma subtypes. Against this background, clinical management of especially the rare lymphomas remains a challenge for the general oncologist. This book provides a comprehensive overview of current treatment strategies in these rare lymphoma subtypes. Experts in the field from around the world describe the histomorphology in a clinically relevant manner, consider the role of risk factors in detail, and discuss the spectrum of therapeutic approaches. Special emphasis is placed on the translation of molecular science into clinical care, and a disease-specific algorithm is proposed for each entity. This book will prove an excellent resource for both experienced and inexperienced practitioners.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
988			_aEBOOK, asignarmaterias, EBSPRINGER,
650		7	_aLinfomas _0(OCoLC)1004321 _2embne _0 _9668066
650	1	7	_aSalud pública _0 _2embne _9138408
700	1		_aDreyling, Martin _eeditor literario _988766 _0Local
700	1		_aWilliams, Michael E _eeditor literario _988767 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-642-39590-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12882690 _b10-10-17 _c11-11-15
998			_am _a_alco _a_vill _b11-11-15 _cm _dz _e- _feng _ggw _h0
945			_aRC280.L9 R374 2014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11562511 _z06-04-17
999			_c80516 _d80516 _x1